ripekg:author/RIPEAU882DB576EE01EE93Marco Gandarillas |
rdf:type |
node1 |
ripekg:author/RIPEAU882DB576EE01EE93Marco Gandarillas |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAU882DB576EE01EE93Marco Gandarillas |
rdf:type |
owl:Thing |
ripekg:author/RIPEAU882DB576EE01EE93Marco Gandarillas |
rdf:type |
prov:Person |
ripekg:author/RIPEAU882DB576EE01EE93Marco Gandarillas |
rdf:type |
foaf:Person |
ripekg:author/RIPEAU882DB576EE01EE93Marco Gandarillas |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAU882DB576EE01EE93Marco Gandarillas |
owl:sameAs |
https://semopenalex.org/author/A5111789262 |
ripekg:author/RIPEAU882DB576EE01EE93Marco Gandarillas |
http://www.w3.org/ns/org#memberOf |
ripekg:organization/RIPEO17A7E9709593CB16Marqués de Valdecilla Research Institute (IDIVAL) |
ripekg:author/RIPEAU882DB576EE01EE93Marco Gandarillas |
foaf:familyName |
Gandarillas |
ripekg:author/RIPEAU882DB576EE01EE93Marco Gandarillas |
foaf:givenName |
Marco |
ripekg:author/RIPEAU882DB576EE01EE93Marco Gandarillas |
foaf:name |
Marco Gandarillas |
ripekg:work/10.1186%2Fs13063-020-04400-4Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial |
dcterms:creator |
ripekg:author/RIPEAU882DB576EE01EE93Marco Gandarillas |